| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |